FG001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FG001, covering 2024-11-12 to 2024-11-12. Get the full timeline:
Most recent: Clinical Trial Update: FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery [Phase 2]